New Horizon Health Ltd. has filed an application for the appointment of joint provisional liquidators (JPLs) with the Grand Court, scheduled for a hearing on August 6, 2025. This step aims to transfer the company's business and affairs to independent professional court officers to safeguard shareholder interests. The JPLs, if appointed, will investigate issues highlighted in previous announcements and explore potential restructuring options. Trading of the company's shares remains suspended since March 28, 2024, pending further updates. Shareholders and investors are advised to exercise caution when dealing with the company's securities.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。